Anatomic Pathology Market

Global Anatomic Pathology Market Size (2024 to 2029)

As per our report, the global anatomic pathology market is predicted to reach USD 31.29 billion by 2029 from USD 23.21 billion in 2024. The market is forecasted to grow at a CAGR of 6.16% during the forecast period. The use of anatomic pathology with biomarkers in diagnosing cancer is hugely impacting the market's growth rate positively.

Current Scenario of the Anatomic Pathology Market

The anatomic pathology market has grown tremendously in recent times due to the adoption of artificial intelligence tools and technological advances. For instance, in November 2023, an end-to-end AI-based Digital Pathology solution was introduced by Ibex and Dedalus for cancer patients. So, anatomical pathology for diagnostic accuracy is fuelled by AI-powered instruments. Also, with the advent of artificial intelligence, the healthcare industry is one of the rapid adopters of this for improving the efficacy of diagnosis, treatment, and patient results. Similarly, to provide the pathology team with better diagnostic precision and build further effective treatment strategies the Anatomical Pathology Laboratory at Sheikh Shakhbout Medical City are using AI technology. It is an advanced center in UAE. The healthcare industry in the Middle East is swiftly investing in generative AI. Likewise, the world’s biggest AI-powered biotechnology research centre was opened in Abu Dhabi in 2023 by Insilico Medicine for drug discovery. In past 1 or 2 years few studies or research paper have also been published regarding the application of chatbot systems in Routine Diagnostic Pathology.

However, there are challenges which are derailing the expansion of the anatomical pathology market. And one of them is the shortage of workforce and handling antimicrobial immunity. Take the example of the United Kingdom where antimicrobial resistance is a serious risk. For this the Three-Year Strategic Plan 2023–2026 of the UK Health Security Agency (UKHSA) has stated the necessity of strong monitoring, immediate diagnosis and great antimicrobial stewardship (AMS). Furthermore, apart from their laboratory responsibilities, virologists and medical microbiologists are accepting additional patient-facing jobs. Hence, this has created the need for prompt emphasis on some pathology reconfiguration, higher healthcare and biomedical staff with mixed skills and newer diagnostics.

MARKET DRIVERS

The rising aging population worldwide and increasing incidences of chronic diseases due to changes in food habits and lifestyle are primarily accelerating the global anatomic pathology market.

Y-O-Y demand to improve the diagnostic procedures in clinical centers, increasing concern towards health and priority for early diagnosis and a rise in disposable income in urban areas are expected to boost the market’s growth rate. The growing adoption of the latest technologies and the launch of innovative techniques in the medical sector are estimated to favor the anatomic pathology market growth. In addition, the growing prevalence of effective treatment procedures and the promotion of the patient's well-being after surgeries create opportunities for the anatomic pathology market. Increasing investments in hospital construction by the government are likely to bolster the anatomic pathology market.

MARKET RESTRAINTS

The shortage of skilled professionals to examine tissues and cells accurately in anatomic pathology in some countries is hampering the growth rate of the worldwide market.

The high cost associated with diagnostic tests for anatomic pathology is another key factor hindering market growth. Unfavourable reimbursement policies for anatomic pathology tests in some countries are impeding market growth. The slow adoption of new technologies and stringent regulatory environment for anatomic pathology are further impacting the market growth negatively. Limited access to technological advancements in underdeveloped and developing countries, changing healthcare policies, and ethical and legal issues related to patient privacy and consent are limiting the growth rate of the market.

Impact Of COVID-19 On the Global Anatomic Pathology Market

The anatomic pathology market has experienced a mixed impact from the COVID-19 pandemic. On one side, the demand for anatomic pathology tests has grown notably during the COVID-19 pandemic to test the presence of the virus in the human body, which has favored market growth. On the other side, the COVID-19 pandemic has created severe disruption in the supply chain ecosystem and caused a decline in the growth rate of the anatomic pathology market due to the shortages of essential supplies and materials for anatomic pathology labs. During the COVID-19 pandemic, the anatomic pathology labs have had to work continuously to address the increased need to test COVID-19 cases and the anatomic pathology labs have increasingly invested amounts to provide security in terms of PPE kits to the workforce. Likewise, the COVID-19 pandemic has shown a mixed impact on the growth of the anatomic pathology market. However, considering the reduced impact of COVID-19 impact and increased habituation of new normalization by people and companies, the global market for anatomic pathology is predicted to showcase a healthy CAGR in the coming future.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global Anatomic Pathology Market Analysis By Product

The instruments segment led the anatomic pathology market in 2023. Changes in lifestyles and food habits, a rise in the incidences of various health disorders, and growing expenditure on healthcare are majorly elevating the growth of the anatomic pathology market. In addition, in the medical sector, there is a growing need to improve diagnostic procedures and analyze the issue with a clear vision to promote effective treatment for the patient, significantly influencing the market growth.     

Global Anatomic Pathology Market Analysis By End-User

The diagnostics lab segment dominated the anatomic pathology market in 2023. Increasing support from private and public organizations in healthcare centers is accelerating the market's demand. Growing awareness of the availability of various diagnostic procedures for many health disorders is likely to outshine the market's growth. In addition, the rise in the number of research institutes in the medical sector is lavishing the development of the anatomic pathology market.

Global Anatomic Pathology Market Analysis By Application

The lymphoma segment led a significant share of the anatomic pathology market owing to the growing adoption of the latest technology in diagnosing and treating the disease. Increasing disposable income, especially in urban areas, and the growing tendency to launch innovative devices in favor of the end-users are ascribed to bolstering the growth of the anatomic pathology market. The rise in revenue in developed and developing countries also magnifies the significant growth rate of the anatomic pathology market.

REGIONAL ANALYSIS

North America accounted for the leading share of the global market in 2021. The rise in awareness of diagnostic procedures is driving the growth of the anatomic pathology market in North America. Besides, the growing number of research institutes to improve performance boosts the market's demand. As a result, the U.S. is expected to account for most of the share in the North American market during the forecast period.

APAC was right behind the North American market in accounting for the leading share worldwide in 2023 and is predicted to register the fastest CAGR during the forecast period. The growing geriatric population is one factor outshining the business's demand. Also, increasing hospitals' construction with the latest equipment is broadening the growth of the anatomic pathology market.

Europe witnessed the fastest growth rate in the past few years and is expected to have a significant growth rate in the coming years. Furthermore, acceptance of the latest technologies and implementation of new devices at a high success rate are escalating European market demand.

Latin America is forecasted to grow at a CAGR of 6.93% from 2024 to 2029.

The market in the Middle East and Africa is expected to have slight variations in the growth rate.

KEY PLAYERS IN THE GLOBAL ANATOMIC PATHOLOGY MARKET

Noteworthy companies in the global anatomic pathology market profiled in this report are F. Hoffmann-La Roche AG, NeoGenomics Laboratories Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Quest Diagnostics Incorporated, Agilent Technologies, Danaher Corporation, Sakura Fine Technical Co. Ltd., Metropolis, and BISWorld's Pathology Services.

RECENT HAPPENINGS IN THE MARKET

• Roche Company completed the acquisition of Spark Therapeutics in 2019.

• Sarepta Therapeutics Company collaborated with Roche in Dec 2019. As a result, Roche has signed an agreement to use investigation gene therapy outside the US, developed by Sarepta.

DETAILED SEGMENTATION OF THE GLOBAL ANATOMIC PATHOLOGY MARKET INCLUDED IN THIS REPORT

This research report has segmented and sub-segmented the global haemophilia management market based on the type, drug, and region.

By Product

• Instruments
• Accessories

By End-User

• Diagnostics Lab
• Physicians' Office Lab
• Hospitals

By Application

• Lymphoma
• Breast
• Lung
• Cervical
• Colorectal
• Prostate

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa